Financials
Financial year 2025
DE BIE T. from Affligem, company number BE0832636914, closed financial year 2025 with a result of € 68,017 after tax. For that financial year DE BIE T. recorded a gross margin of € 477,359 and equity of € 699,523. Compared with financial year 2024, the result moved from € 101,747 to € 68,017. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 699,523
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 68,017
▼ 33% vs 2024
Profit after tax over the fiscal year.
€ 164,529
▼ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 462,123.
People and assets in 2025
2.9
▼ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 197,781
▲ 2% vs 2024
€ 68,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 14,327
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.1 million
▲ 17% vs 2024
€ 131,809 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 189,508
▲ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,180
▲ 8% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 380,879 | € 413,761 | € 473,941 | € 477,359 | ▲ 1% |
| Profit after taxes | € 90,471 | € 36,318 | € 101,747 | € 68,017 | ▼ 33% |
| Equity | € 502,223 | € 534,860 | € 633,186 | € 699,523 | ▲ 10% |
| Total debts | € 725,451 | € 1,345,422 | € 1,514,442 | € 1,752,188 | ▲ 16% |
| Cash | € 374,201 | € 213,169 | € 244,334 | € 164,529 | ▼ 33% |
| Land & buildings | € 473,305 | € 1,054,774 | € 1,005,873 | € 956,971 | ▼ 5% |
| Retained profit | € 264,823 | € 297,460 | € 395,786 | € 462,123 | ▲ 17% |
| Bank debt | € 283,023 | € 849,907 | € 939,853 | € 1,101,797 | ▲ 17% |
| Balance sheet total | € 1,227,674 | € 1,880,282 | € 2,147,627 | € 2,451,711 | ▲ 14% |
| Employees (FTE) | 2.6 | 3.7 | 3.9 | 2.9 | ▼ 1 |
Key figures of DE BIE T., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to DE BIE T.?
What happened at DE BIE T. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 68,017 (▼ 33% vs 2024). Source: NBB ↗
- New establishment in Aalst. KBO
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
In short
From € 90,471 profit in 2022 to € 68,017 profit in 2025.
Paid € 138,670 in corporate taxes since 2022.
Best year ever: 2024, with € 101,747 profit.
On average € 164,600 of value added per employee in 2025.
Management
Behind DE BIE T. is Tineke De Bie. Tineke De Bie is also behind Immoferm.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Aalsterse Dreef 30
1790 Affligem
Langestraat 239
9300 Aalst
Active since 10 January 2011
Onze Lieve Vrouwplein 13
9300 Aalst
Active since 10 January 2011
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0832.636.914
- VAT number
- BE 0832.636.914
- Registered office
- Aalsterse Dreef 30, 1790 Affligem
- Names & denominations
- DE BIE T.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2011
- Peppol
- Active · Active since 20 May 2026
- Activities · NACE
Detailhandel in farmaceutische producten